Abcentra Appoints Entrepreneur and Cardiologist Michael H. Davidson to Board of Directors

LOS ANGELES: LOS ANGELES, Oct. 14, 2021 /PRNewswire/ -- Abcentra LLC announced today that Michael H. Davidson, MD, has been appointed to the Board of Directors. Dr. Davidson is currently CEO of New Amsterdam Pharma, and was previously the founding CEO and Chief Medical Officer of Corvidia Therapeutics, which was...

Click to view original post